FY2025 · ended Dec 31, 2025 · Revenue $236.35M, +15.4% YoY · Filed Mar 4, 2026
OrthoPediatrics Corp (KIDS) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $236.3 million and a net loss of $39.6 million. Free cash flow was -$16.0 million. As of Sep 30, 2026 it held $44.2 million in cash and investments and $104.6 million in total debt.
Revenue (TTM)
$264.13M
+16.1% vs year-ago TTM
Net income (TTM)
$-33.88M
+25.7% vs year-ago TTM
Operating cash flow (TTM)
$12.49M
+165.1% vs year-ago TTM
Free cash flow (TTM)
$3.18M
+110.8% vs year-ago TTM
EPS (TTM)
$-1.42
+27.3% vs year-ago TTM
Dividend per share
None
Shares outstanding
25.28M
+4.1% vs prior year
Net cash
$-60.38M
as of Sep 30, 2026
Operating margin
-9.4%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- KIDS (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Warsaw, IN
- SEC filer status
- Accelerated filer
- SEC CIK
- 1425450
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $236.3M | $204.7M | $148.7M | $122.3M | $98.0M |
| Operating income | -$39.2M | -$35.0M | -$26.8M | -$25.4M | -$18.0M |
| Net income | -$39.6M | -$37.8M | -$21.0M | $1.3M | -$16.3M |
| Diluted EPS | -$1.69 | -$1.64 | -$0.92 | $0.06 | -$0.84 |
| Operating cash flow | -$4.9M | -$27.0M | -$27.0M | -$21.8M | -$13.1M |
| Free cash flow | -$16.0M | -$41.3M | -$43.9M | -$31.8M | -$21.2M |
| Total assets | $508.6M | $473.2M | $438.7M | $427.7M | $304.3M |
| Total liabilities | $162.0M | $118.6M | $61.7M | $49.1M | $78.9M |
| Stockholders' equity | $346.6M | $354.6M | $377.0M | $378.6M | $225.4M |
| Cash and investments | $60.9M | $68.8M | $80.3M | $109.3M | $53.5M |
| Total debt | $118.0M | $85.3M | $12.1M | $1.2M | $1.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 28, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 27, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 27, 2026 | Oct 27, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
All 628 OrthoPediatrics Corp SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.